Joseph F. Goldberg, MD
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Corresponding Author: Joseph F. Goldberg, MD, 128 East Ave, Norwalk, CT 06851 ([email protected]).
Consensus Statement
Screening, Diagnosis, and Treatment of Tardive Dyskinesia
January 28, 2020
Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.